Trials / Completed
CompletedNCT01056328
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
Irrigated Ablation System Evaluation for AF
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 324 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SJM Irrigated Cardiac Ablation System | Irrigated ablation catheter |
| DEVICE | FDA approved Open Irrigated RF Ablation System | Irrigated ablation catheter |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2010-01-26
- Last updated
- 2019-02-26
- Results posted
- 2014-05-23
Locations
30 sites across 3 countries: United States, Canada, South Korea
Source: ClinicalTrials.gov record NCT01056328. Inclusion in this directory is not an endorsement.